This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
antibody
product name :
MMP-1 Antibody, clone 2A7.2
catalog :
MAB13438
quantity :
100 µg
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
2A7.2
reactivity :
human
application :
western blot, ELISA
product information
Catalog Number :
MAB13438
Subcategory :
Cell Structure
Product Name :
Anti-MMP-1 Antibody, clone 2A7.2
Product Type :
Antibodies
Clonality :
Monoclonal Antibody
Gene ID :
P03956
Host Name :
Mouse
Antigen :
MMP-1
Clone :
2A7.2
Conjugate :
Purified
Isotype :
IgG1
Product Description :
Anti-MMP-1 Antibody, clone 2A7.2
Cross Reactivity :
Human
ALT Names :
Fibroblast Collagenase; Interstitial Collagenase
Immunogen :
Synthetic peptide corresponding to the amino terminal region of human MMP-1.
Specificity :
Antibody MAB13438 is directed against a synthetic peptide corresponding to the amino terminal region of human MMP-1. The antibody binds to MMP-1 but does not cross-react with the other MMP family members (MMP-2, MMP-3, MMP-9, etc.).
SPECIES REACTIVITIES: Other species not tested; however this sequence of MMP-1 is well conserved across species. Higher concentrations of antibody may be needed for non-human samples.
Package Size :
100 µg
Uses :
ELISA;Western Blotting
Storage :
Maintain at 2-8°C in undiluted aliquots for up to 12 months.
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany
Hundreds of New Antibodies in the areas of:
View all the new antibodies at www.emdmillipore.com.
Hundreds of New Antibodies in the areas of:
|
|
questions and comments